NBT Bank N.A. Acquires New Position in CVS Health Corporation $CVS

NBT Bank N.A. acquired a new stake in shares of CVS Health Corporation (NYSE:CVS) during the third quarter, HoldingsChannel reports. The firm acquired 37,187 shares of the pharmacy operator’s stock, valued at approximately $3,187,000.

A number of other large investors have also modified their holdings of the company. Root Financial Partners LLC boosted its position in shares of CVS Health by 7.7% during the 3rd quarter. Root Financial Partners LLC now owns 5,790 shares of the pharmacy operator’s stock valued at $496,000 after acquiring an additional 416 shares in the last quarter. Investment House LLC increased its stake in CVS Health by 16.9% in the third quarter. Investment House LLC now owns 10,391 shares of the pharmacy operator’s stock valued at $890,000 after acquiring an additional 1,503 shares during the period. E. Ohman J or Asset Management AB increased its stake in CVS Health by 3.3% in the third quarter. E. Ohman J or Asset Management AB now owns 31,455 shares of the pharmacy operator’s stock valued at $2,695,000 after acquiring an additional 1,000 shares during the period. Marion Wealth Management increased its stake in CVS Health by 82.8% in the third quarter. Marion Wealth Management now owns 3,738 shares of the pharmacy operator’s stock valued at $320,000 after acquiring an additional 1,693 shares during the period. Finally, Kachkovsky & Fisher Inc. acquired a new position in CVS Health in the third quarter worth about $201,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Up 1.2%

CVS opened at $94.54 on Friday. The firm’s 50-day simple moving average is $91.67 and its 200-day simple moving average is $93.78. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68. The firm has a market cap of $120.92 billion, a price-to-earnings ratio of 25.01, a PEG ratio of 0.87 and a beta of 0.60.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business had revenue of $106.10 billion during the quarter, compared to analysts’ expectations of $100.03 billion. During the same quarter last year, the company posted $1.81 EPS. The firm’s revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities research analysts anticipate that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd will be issued a dividend of $0.6650 per share. The ex-dividend date of this dividend is Thursday, October 22nd. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. CVS Health’s dividend payout ratio (DPR) is presently 70.37%.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Barclays raised their price target on shares of CVS Health from $106.00 to $108.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Wells Fargo & Company upped their price objective on CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. UBS Group reissued a “buy” rating on shares of CVS Health in a report on Tuesday, September 22nd. HSBC restated a “hold” rating and set a $103.00 target price on shares of CVS Health in a research report on Monday, July 6th. Finally, JPMorgan Chase & Co. raised their target price on CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Twenty research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $107.80.

About CVS Health

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.